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Abstract
Lithium is a widely used mood stabilizer, which may cause cardiac side effects. In this article, we
present the case of a 39-year-old woman who had presented with pre-syncope and developed
multiple ECG abnormalities that are caused by lithium intoxication and are disappeared after
hemodialysis.
Introduction
Lithium salts are widely used in psychiatric therapy and
prophylaxis as mood stabilizers. The mechanism as a
mood-stabilizing agent remains unknown, although
effects on biologic membranes are speculated. A serum
level between 0.8 mEq/l and 1.2 mEq/l is considered ther-
apeutic, usually obtained with a dose of approximately
900 to 1200 mg/day [1].
The cardiac side effects of lithium have been well
described at a wide range of plasma concentrations [2,3].
Lithium salts may induce various electrocardiographic
(ECG) changes including nonspecific T-wave flattening
[2], dysfunction of sinus node [4-6], and prolonged QT
interval [7,8]. In rare cases, ventricular tachycardia and
ventricular fibrillation resulting in death have been
reported [2].
Herein, we describe the case of a 39-year-old woman who
had presented with pre-syncope and developed multiple
ECG abnormalities that are caused by lithium intoxica-
tion and are disappeared after hemodialysis.
Case report
A 39-year-old female patient with a history of bipolar dis-
order and mental retardation was admitted to emergency
service with agitation and elevated mood. She had been
using various mood stabilizers irregularly until she had
discontinued her treatment (Valproic acid 1 gr/day) 3
months ago. The condition was diagnosed as "manic epi-
sode" according to DSM-IV-TR criteria and she was
administered intramuscular ziprasidone 20 mg and
started on lithium (1200 mg/day, 3 times per day).
After 5 days, she was admitted to emergency service again
with the complaints of fainting, altered mental status, and
motor weakness particularly of lower extremities. She was
found to be unable to walk and follow simple commands.
Her initial vital signs were normal (BP: 130/90 mmHg,
HR: 52 beats/minute). Her laboratory findings were nota-
Published: 17 September 2008
Cases Journal 2008, 1:156 doi:10.1186/1757-1626-1-156
Received: 26 July 2008
Accepted: 17 September 2008
This article is available from: http://www.casesjournal.com/content/1/1/156
© 2008 Canan et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cases Journal 2008, 1:156 http://www.casesjournal.com/content/1/1/156
Page 2 of 4
(page number not for citation purposes)
ble for hypokalemia with a potassium level of 2.72 mEq/
l (normal range: 3.2–5.1), and hypophosphatemia (1.26
mEq/l) (normal range: 2.7–4.5). Her serum lithium level
was 2.96 mEq/l (therapeutic level: 0.8–1.2), indicating
lithium intoxication. She was hospitalized for hemody-
namic support and urgent hemodialysis.
The patient's ECG (Figure 1) was remarkable for expanded
p-wave (180 msec), expanded QRS (120 msec), pro-
longed QT (640 msec) and PR (320 msec) interval, ST
wave depression in leads V2 and V3, and common T wave
inversion (Figure 1).
After hemodialysis, the patient's lithium level decreased
to 0.57 mEq/l and her general condition improved rap-
idly. Her control ECG (Figure 2) revealed no abnormali-
ties except T wave inversions and slight ST depression in
leads V2 and V4. She was discharged from the hospital
with risperidone 4 mg/day and recommended psychiatric
follow-up.
Discussion
Lithium salts are highly water-soluble and are well
absorbed by the gastrointestinal tract. Complete absorp-
tion occurs in about 8 hours, with peak concentrations
occurring 2 to 4 hours after an oral dose. Lithium is ini-
tially distributed in the extra cellular fluid and then accu-
mulates gradually in various tissues. Approximately 95%
of a single dose of lithium is eliminated in the urine; with
repeated administration, the excretion increases until a
steady state is reached after 5 to 7 days [9].
Animal experiments indicate that lithium depresses the
intracellular potassium concentration. In addition lith-
ium replaces intracellular calcium [10]. These distur-
bances seem to induce various electrophysiological
changes including a decrease of the depolarization rate
and reduced electrical impulse propagation [11]. It has
also been suggested that lithium might decrease the sensi-
tivity of the sinus node to sympathetic stimulation [12].
Interaction between lithium and several currents such as
IK, ICa, the Na/Ca exchange current, and a Na/K pump
Twelve-Lead ECG at admission (PR: 320 msec, QRS: 120 msec, QT: 640 msec) Figure 1
Twelve-Lead ECG at admission (PR: 320 msec, QRS: 120 msec, QT: 640 msec).Cases Journal 2008, 1:156 http://www.casesjournal.com/content/1/1/156
Page 3 of 4
(page number not for citation purposes)
current might lead to the observed results [13]. It is indef-
inite whether cardiac effects in patients receiving lithium
are caused by lithium toxicity, or are a co-incidental find-
ing. The two appear to be causally linked, as indicated by
our case report.
The clinical features and optimal management of lithium
intoxication have recently been reviewed [14]. This indi-
cates that haemodialysis is generally more effective in lith-
ium clearance than other modalities, for example,
haemofiltration. However, it appears that prolonged
haemodialysis (> 16 hours) is required in order to prevent
'rebound' of lithium concentrations. Prolonged hemodi-
alysis appears necessary to allow adequate tissue removal
of lithium. Although we did not perform single-day pro-
longed hemodialysis, we accept it as a logical way of treat-
ment since we had to perform four days of serial
hemodialysis consecutively in our patient in order to
decrease lithium level to therapeutic range.
A key area of importance of our case report is that our
patient developed severe clinical features, whereas lithium
concentrations were only modestly elevated. This is the
main characteristic of chronic lithium poisoning, as
described by Waring et al. [15]. Lithium concentrations >
5 mmol/L might be used to indicate a need for haemodi-
alysis after acute lithium overdose, whereas, a much lower
treatment threshold is recommended for chronic toxicity,
or acute-on-therapeutic toxicity (and the clinical features
are much more important guide than blood levels for
chronic poisoning).
The uses of lithium continue to expand with an increas-
ingly larger population. This case report shows that lith-
ium toxicity can occur even in therapeutic dosages
particularly when combined with other medications such
as ziprasidone.
Twelve-Lead ECG after hemodialysis (PR: 150 msec, QRS: 60 msec, QT: 360 msec) Figure 2
Twelve-Lead ECG after hemodialysis (PR: 150 msec, QRS: 60 msec, QT: 360 msec).Publish with BioMed Central    and   every 
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Clinicians should be vigilant to cardiac risks and ECG
changes associated with lithium toxicity, including all
kinds of arrhythmias that can occur abruptly in the first
days of the treatment.
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